Riskpilot← Back to searchSign inGet full accessOy JJAV Ab
OYDissolvedY-tunnus 2838604-8Ullankatu 3-A10Medical specialists activities · NACE 8622Est. 20171 employees
Revenue 2025
EUR 376K
+2% vs 2024
EBITDA margin
34.2%
+10% vs 2024
Equity ratio
99.8%
Financial strength
Net profit 2025
EUR 196K
+127% vs 2024
| Revenue | EUR 376K | +2% |
| EBITDA | EUR 129K | +10% |
| Net profit | EUR 196K | +127% |
| Total assets | EUR 997K | +14% |
| Equity | EUR 995K | +15% |
| Employees | 1 | — |
Legal name
Oy JJAV Ab
Y-tunnus number
2838604-8
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
8. kesäkuuta 2017
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Company purpose
Yhtiön toimialana on lääkäri- ja muiden terveydenhoitopalvelujen tuottaminen potilaille, alan koulutus, konsultaatio- ja luennointipalvelut sekä tutkimus- ja tuotekehitystoiminta. Yhtiö voi harjoittaa terveydenhoito- ja kuntoutusalan laitteiden ja tarvikkeiden suunnittelua, maahantuontia ja maastavientiä sekä tukku- ja vähittäiskauppaa. Yhtiö voi harjoittaa taideteosten keräilyä ja kauppaa ja järjestää taidenäyttelyitä. Yhtiö voi omistaa, hallita ja vuokrata kiinteistöjä, asuin- ja liikehuoneistoja sekä kulkuneuvoja. Yhtiö voi harjoittaa arvopaperikauppaa.
Address
Ullankatu 3-A10
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 284 | 413 | 395 | 369 | 376 |
| Staff expenses | −5 | −76 | −91 | −139 | −137 |
| EBITDA | 220 | 243 | 207 | 117 | 129 |
| Depreciation & amort. | −9 | −9 | −9 | −9 | −9 |
| EBIT | 212 | 234 | 198 | 108 | 120 |
| Net financials | −2 | 15 | 27 | 5 | 126 |
| Profit before tax | 210 | 248 | 226 | 114 | 246 |
| Tax | 46 | 50 | 45 | 27 | 50 |
| Net profit | 206 | 199 | 181 | 86 | 196 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 716 | 743 | 851 | 873 | 997 |
| Equity | 575 | 728 | 851 | 869 | 995 |
| Long-term debt | — | 0 | 0 | 0 | 0 |
| Short-term debt | 140 | 15 | 0 | 4 | 2 |
| Total debt | 140 | 15 | 0 | 4 | 2 |
EBITDA margin
34.2%
This company
15.8%
Market median
+116% vs market
20212025
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20212025
Return on equity
19.7%
This company
18.4%
Market median
+7% vs market
20212025
Net profit margin
52.1%
This company
8.1%
Market median
+543% vs market
20212025
Asset turnover
0.38×
This company
1.12×
Market median
-66% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-11-01 – 2025-10-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-11-01 – 2022-10-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-11-01 – 2021-10-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
JA | Audit | 2025 |
AA Deputy Member | Deputy Member | 2017 |
PR Deputy auditor | Deputy auditor | 2025 |
JP Chief Executive Officer | Chief Executive Officer | 2017 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Oy JJAV Ab also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jose Adam Juhani Kautonen | Audit | 0 companies |
| Aki Antero Vuokko | Deputy Member | 0 companies |
| Petteri Raine Lagus | Deputy auditor | 0 companies |
| Jere Pekka Järvenpää | Chief Executive Officer | 0 companies |